VECCHIET, Jacopo
 Distribuzione geografica
Continente #
NA - Nord America 5.703
EU - Europa 5.463
AS - Asia 2.409
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 8
AF - Africa 7
OC - Oceania 4
Totale 13.606
Nazione #
US - Stati Uniti d'America 5.683
CN - Cina 1.193
IE - Irlanda 1.124
UA - Ucraina 1.066
TR - Turchia 802
SE - Svezia 798
IT - Italia 746
GB - Regno Unito 626
FR - Francia 382
DE - Germania 369
IN - India 271
FI - Finlandia 201
BE - Belgio 82
KR - Corea 70
VN - Vietnam 25
CA - Canada 16
RO - Romania 13
RU - Federazione Russa 13
IL - Israele 12
EU - Europa 11
IR - Iran 9
NL - Olanda 9
HK - Hong Kong 7
SG - Singapore 7
CH - Svizzera 6
JP - Giappone 5
AT - Austria 4
GR - Grecia 4
AR - Argentina 3
BG - Bulgaria 3
EE - Estonia 3
ES - Italia 3
ET - Etiopia 3
MX - Messico 3
NZ - Nuova Zelanda 3
BR - Brasile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HU - Ungheria 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BN - Brunei Darussalam 1
CL - Cile 1
CO - Colombia 1
HR - Croazia 1
KH - Cambogia 1
LI - Liechtenstein 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SC - Seychelles 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 13.606
Città #
Jacksonville 1.292
Chandler 1.259
Dublin 1.104
Southend 551
Princeton 536
Izmir 431
Nanjing 396
Ashburn 272
Altamura 211
Wilmington 205
Cambridge 200
Beijing 193
Dearborn 181
Chieti 127
Nanchang 125
Ann Arbor 110
Boardman 89
Brussels 80
Shenyang 69
Grevenbroich 60
Woodbridge 58
Kunming 55
New York 52
Tianjin 51
Hebei 50
Jiaxing 47
Washington 44
Norwalk 39
Pune 39
Hangzhou 34
Changsha 32
Jinan 27
Pescara 27
Seattle 27
Augusta 26
Falls Church 26
Dong Ket 24
Rome 23
San Mateo 22
Changchun 17
Orange 16
Helsinki 15
Auburn Hills 14
Guangzhou 14
Kocaeli 14
Lanzhou 14
Houston 12
Ningbo 12
Toronto 11
Leawood 10
Hefei 9
Milan 9
Düsseldorf 8
San Vito Chietino 8
Taizhou 8
Zhengzhou 8
Andover 7
San Giovanni 7
Tappahannock 7
Los Angeles 6
Simi Valley 6
Ardabil 5
Clarks Summit 5
Montesilvano 5
Mumbai 5
Albenga 4
Amsterdam 4
Aquila 4
Campobasso 4
Carmine 4
Cedar Knolls 4
Chicago 4
Fuzhou 4
Hong Kong 4
Lanciano 4
Monmouth Junction 4
Novara 4
Putignano 4
Redmond 4
Singapore 4
Taranto 4
Vienna 4
Addis Ababa 3
Auckland 3
Bangalore 3
Castellalto 3
Edinburgh 3
Florence 3
Frankfurt am Main 3
Gela 3
Giulianova 3
Haikou 3
Hanover 3
L'aquila 3
London 3
Meieki 3
Molise 3
Moscow 3
Napoli 3
New Delhi 3
Totale 8.568
Nome #
Visceral and somatic hypersensitivity in patients with the irritable bowel syndrome (IBS) 112
Relevance of plant lectins in human cell biology and immunology 102
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 95
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 94
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 93
Sodium nitroprusside, a NO donnor, modifies Ca2+ transport and mechanical properties in frog skeletal muscle 91
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 90
Metabolic modifications in HIV-infected women 90
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 88
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 87
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 86
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 86
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 84
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 84
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 84
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 83
Alterations in muscles of CFS patients at morphological. biochemical and molecular level. 82
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 82
Muscle Pain from Physical Exercise 80
Substance P upregulates LTB4 in rat adherent macrophages from granuloma induced by KMnO4 80
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 80
Visceral pain mechanisms 79
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 79
Inflammatory compounds: neuropeptide substance P and cytokines 78
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 78
Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line 77
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 76
Autism and immunity: revisited study 76
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 76
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 76
Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. 75
Capsaicin an irritant anti-inflammatory compound. 75
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 75
IL-32: a newly-discovered proinflammatory cytokine 74
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 74
Il ruolo della sindrome miofasciale nell'attivazione della sintomatologia dolorosa della sindrome fibromialgica. 73
Age and sex influence on oxidative damage and functional status in human skeletal muscle. 73
Chemokines as markers for parasite-induced inflammation and tumors 73
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 72
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 71
Visceral and somatic hypersensitivity in patients with Irritable Bowel Syndrome (IBS) 71
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 71
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. 71
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 70
Inter-relationship between chemokines and mast cells 70
Hypertension in HIV: Management and Treatment 69
Patient-reported and Physician-estimated Adherence to HAART. 69
Visceral Pain Mechanism 68
Localization and activity of iNOS in normal human lung tissue and lung cancer tissue 68
In vitro activity of clarithromycin against intracellular Helicobacter pylori. 68
Effetti del trattamento con vitamina E sulla sintomatologia muscolo-scheletrica soggettiva ed oggettiva della Sindrome da Fatica Cronica 68
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 68
Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome 67
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 67
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 67
Acute urinary retention due to HSV-1: a case report 67
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 67
Referred Muscle Pain: Clinical and Pathophysiologic Aspects 67
Mast cells and arachidonic acid cascade in inflammation 67
Is the rate of virological failure to cART continuing to decline in recent calendar years? 67
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 67
Role of quercetin (a natural herbal compound) in allergy and inflammation. 67
MtDNA deletions in aging and in nonmitochondrial pathologies. 66
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 66
Transcription profile analysis of Vastus lateralis muscle from patients with chronic fatigue syndrome. 66
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 66
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 66
Il ruolo della sindrome miofasciale nell'attivazione della sintomatologia dolorosa della sindrome fibromialgica 65
Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. 65
Biology of neurotensin: revisited study 65
Role of mast cells in tumor growth 65
Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells 65
Contribution of the Leifson stain to the detection of Helicobacter pylori from antral biopsy specimens. 65
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 65
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 65
Interleukin-31: a new cytokine involved in inflammation of the skin 64
Rantes potentiates human macrophage aggregation and activation responses to calcium ionophore (A23187) and activates arachidonic acid pathways. 64
Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells 64
High dose of erythropoietin in management of interferon/ribavirin induced anemia 64
Antioxidant pathways in human aged skeletal muscle: relationship with the distribution of type II fibers. 64
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 64
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 63
Inguinal lymphadenopathy due to Bartonella henselae 63
Age and sex differences in human skeletal muscle: role of reactive oxygen species. 63
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 63
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 63
Antiretroviral therapy management and rationalisation of available resources 63
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 62
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 62
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report 62
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 62
Canakinumab in a subgroup of patients with COVID-19 62
The latest interleukin: IL-33 the novelIL-1-family member is a potent mast cell activator. 62
Periodontitis and cytokine patterns in HIV positive patients 61
Ruolo delle citochine nella patogenesi delle malattie infettive 61
Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscle. 61
Role of flavonoids and vitamins in cancer. 61
Alteration of spatial-temporal parameters of gait in Chronic Fatigue Syndrome patients. 60
RANTES (CCL5) potentiates calcium ionophore in the production of LTB4 in rat adherent macrophages from granuloma induced by KMnO4: inhibiton by NDGA. 60
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. 60
Totale 7.192
Categoria #
all - tutte 48.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019537 0 0 0 0 0 0 0 0 4 15 12 506
2019/20202.854 921 197 22 87 210 172 328 253 88 245 301 30
2020/20211.473 233 11 261 17 126 285 33 34 125 188 72 88
2021/20221.163 42 29 19 220 76 34 44 81 91 33 134 360
2022/20233.766 321 544 213 370 357 728 282 312 417 51 99 72
2023/20241.553 126 80 130 78 164 481 409 73 12 0 0 0
Totale 14.487